Adjunctive Semaglutide in Patients Undergoing Intragastric Balloon for Weight Loss: 12-Month Prospective Comparative Study
Adjunctive semaglutide therapy with intragastric balloon (IGB) optimizes weight loss, while enhancing the sustainability achieved with intragastric ballooning alone. This combined therapeutic approach may provide an additional non-invasive intervention that provides optimal results and long-term weight loss maintenance.
Authors
- Marc D. Basson (ORCID: https://orcid.org/0000-0001-9696-2789)
- Matthew Guy (ORCID: https://orcid.org/0000-0002-6818-2010)
- Khaled E. Barakat (ORCID: https://orcid.org/0009-0000-3626-1331)
- Ahmed Adham R. Elsayed
- Mohamed R. Mahmoud (ORCID: https://orcid.org/0000-0002-6835-8813)
- Rama Safadi (ORCID: https://orcid.org/0000-0002-4966-5260)
- Mohamed Asal
- Doaa K. Abuhasan
Institutions
- Egypt-Japan University of Science and Technology (EG)
- Alexandria University (EG)
- Northeast Ohio Medical University (US)
Publication Details
- Journal
- Obesity Surgery
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1007/s11695-025-08368-5
- Citations
- 1
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01